東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Lung cancer screening: Why it is not...

Sluchak-Carlsen, Julia.

FindBook

Google Book

Amazon

博客來

Lung cancer screening: Why it is not being done.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Lung cancer screening: Why it is not being done./
作者:	Sluchak-Carlsen, Julia.
面頁冊數:	95 p.
附註:	Source: Masters Abstracts International, Volume: 43-06, page: 2217.
Contained By:	Masters Abstracts International43-06.
標題:	Health Sciences, Public Health. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1425932
ISBN:	9780542046308

Lung cancer screening: Why it is not being done.
Sluchak-Carlsen, Julia.

Lung cancer screening: Why it is not being done. - 95 p.

Source: Masters Abstracts International, Volume: 43-06, page: 2217.

Thesis (M.I.S.)--Wayne State University, 2005.

Lung Cancer is the second most common cancer and the leading cause of cancer-related deaths in the United States. It has been shown that when treated in its early stages, lung cancer survival rates improve greatly. One way to accomplish this and detect the disease early is with a lung cancer screening program. There exists a need for the tools and technology to accomplish accurate screening. In spite of this need, controversy still remains regarding screening for lung cancer. Major concerns include the lack of validated screening tools, questionable study design and analysis, medical acceptance, and ethical and social concerns. Initiating a screening program is by no means an easy task. Lung cancer screening is a major challenge because of the vary nature of the disease. Detection and diagnosis are extremely difficult. Past research trials have been unsuccessful and have received much criticism. Medical technology has developed better imaging technology that combined with carefully designed research trials may assist medical professionals in screening for lung cancer and halting the progress of the disease.

ISBN: 9780542046308Subjects--Topical Terms:

1017659
Health Sciences, Public Health.

Lung cancer screening: Why it is not being done.
LDR:01962nmm 2200277 4500 001 1827347
005 20061222092054.5
008 130610s2005 eng d
020 $a 9780542046308
035 $a (UnM)AAI1425932
035 $a AAI1425932
040 $a UnM $c UnM
100 1 $a Sluchak-Carlsen, Julia. $3 1916278
245 1 0 $a Lung cancer screening: Why it is not being done.
300 $a 95 p.
500 $a Source: Masters Abstracts International, Volume: 43-06, page: 2217.
500 $a Adviser: Marsha Richmond.
502 $a Thesis (M.I.S.)--Wayne State University, 2005.
520 $a Lung Cancer is the second most common cancer and the leading cause of cancer-related deaths in the United States. It has been shown that when treated in its early stages, lung cancer survival rates improve greatly. One way to accomplish this and detect the disease early is with a lung cancer screening program. There exists a need for the tools and technology to accomplish accurate screening. In spite of this need, controversy still remains regarding screening for lung cancer. Major concerns include the lack of validated screening tools, questionable study design and analysis, medical acceptance, and ethical and social concerns. Initiating a screening program is by no means an easy task. Lung cancer screening is a major challenge because of the vary nature of the disease. Detection and diagnosis are extremely difficult. Past research trials have been unsuccessful and have received much criticism. Medical technology has developed better imaging technology that combined with carefully designed research trials may assist medical professionals in screening for lung cancer and halting the progress of the disease.
590 $a School code: 0254.
650 4 $a Health Sciences, Public Health. $3 1017659
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0573
690 $a 0992
710 2 0 $a Wayne State University. $3 975058
773 0 $t Masters Abstracts International $g 43-06.
790 1 0 $a Richmond, Marsha, $e advisor
790 $a 0254
791 $a M.I.S.
792 $a 2005
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1425932